Livestock

Global president of Brenntag Specialties Pharma, Torsten Walz said that adding K+S' pharmaceutical salts would help strengthen their role as a key supplier to the global healthcare industry. (Image source: Brenntag)

Global chemicals and ingredients distribution market leader, Brenntag Specialties Pharma recently announced a new strategic partnership with globally oriented raw materials company, K+S Minerals and Agriculture GmbH for the worldwide distribution of three pharmaceutical salts

K+S which is one of the world's largest producers of pharmaceutical salts, will have three of their salts distributed by Brenntag. These include APISAL Sodium Chloride GMP grade (in pharmacopoeia quality, API), Potassium Chloride 99.9 % KCl Ph. Eur., USP (API) and HD-NaCl (excipient grade). 

The salts are manufactured using special processes to ensure purity and meeting the strict quality requirements of the pharmacopoeias (European Pharmacopoeia, US Pharmacopeia). Examples for final dosage forms are hemodialysis, infusion and injection solutions, electrolyte preparations and tablets. 

Global president of Brenntag Specialties Pharma, Torsten Walz said that adding K+S' pharmaceutical salts would help strengthen their role as a key supplier to the global healthcare industry.

"Our commitment to providing these important ingredients ensures that our customers worldwide have access to the highest quality components needed to produce effective pharmaceuticals, electrolyte therapies and dietary supplements. With this partnership, we combine decades of experience, because not only we at Brenntag are celebrating our 150th anniversary this year, K+S is also celebrating an important milestone: 135 years of company history,” added Waltz.

Technology developed by the Scottish biotech, which has announced its latest investment round, is set to revolutionise the dairy farming industry. (Image source: Business Wire)

Scottish biotech company, Biotangents recently announced its latest investment round, that is set to revolutionise the dairy farming industry with the world’s fastest on-farm, point-of-care diagnostic device aimed at addressing disease in dairy cows

Bovine mastitis is a serious and expensive problem costing the global dairy farming industry around US$25.4bn every year. Given the timeframe of existing diagnostics, which take so long that farmers resort to treating herds, predominantly with antibiotics.

The excessive use of antibiotics which that is unnecessary for 40% of cases increases the anti-microbial resistance of the herd, decreases life expectancy, and increases milk wastage, leading to negative environmental impact and significant costs. 

Biotangents developed its technology to enable farmers to make an informed treatment decision. Its solution comprises a cost effective, innovative on-farm molecular diagnostic device that provides highly accurate results in less than two hours. 

“Biotangents is on the cusp of full market launch with a technology that leads to better herd health, much improved productivity, and significantly higher levels of sustainability,” said CEO of Biotangents, Fiona Marshall.

Biotangents sees future applications for its technology not only in animal health, but also in human healthcare and environmental monitoring. Following the investment, Biotangents will commence on-farm trials across the UK and internationally later next year.

What makes the new cold plasma mite trap EX stand apart is its process which is complete devoid of additives or acaricides. (Image source: MIK INTERNATIONAL)

In collaboration with the Friedrich Loeffler Institute and the University of Applied Sciences and Arts Hildesheim/Holzminden/Göttingen, MIK INTERNATIONAL GmbH & Co. KG presented its new product “Cold Plasma Mite Trap EX” for the first time at  EuroTier 2024 in Hanover

This system specifically focuses on controlling the red bird mite (Dermanyssus gallinae) in laying hen farms, and was honoured with a gold medal at the event. 

Red mites are one of the most common and economically important ectoparasites globally, with infestations causing massive damage to animal health and economy. Currently organic farming offers minimum options to control red mites, with the most common control method involving the use of acaricides. However, these cannot be used in excess due to the increased likelihood of developing resistance. 

What makes the new cold plasma mite trap EX stand apart is its process which is complete devoid of additives or acaricides. The process works by collecting and killing the mites and their brood in the mite trap. 

By generating a cold atmospheric pressure plasma, which is created by dielectric barrier discharge, the mites are killed highly efficiently and reliably. This can be used highly efficiently against all developmental stages of the red mite. 

After each killing process, the mite trap is automatically cleaned. The complete system is operated with a mains voltage of 230V and consists of a switching unit and at least one mite trap. Currently, 80 “Mite-EX” mite traps can be operated per switching unit.

TARGAN brings AI-driven system WingScan to the European market. (Image source: TARGAN)

Animal AgTech company TARGAN, Inc. recently secured a new contract with IKO Kompania Drobiarska to install TARGAN's automated feather-sexing system, WingScan 

This collaboration debuted at EuroTier 2024 in Hannover, Germany this year, following which it demonstrated TARGAN's commitment to delivering innovative AI-powered solutions to poultry producing companies across Europe. 

Depending on configuration, the WingScan system offers a throughput of 40,000–160,000 chicks per hour, with up to 98% accuracy. Automated chick sexing enhances efficiency and performance, providing downstream benefits at both the farm and processing levels. By implementing gender-specific rearing strategies, producers can improve flock uniformity, ultimately optimising plant operations.

IKO's CEO, Zbigniew Idziaszek expressed pride in being one of the first companies in Europe to integrate WingScan into their hatchery, while looking forward to the positive impact as they continued to expand their operations. He also highlighted how TARGAN's system perfectly aligned with their goals of boosting efficiency, enhancing quality and improving welfare standards across all stages of production.

Viscon Hatchery Automation, TARGAN’s commercial distribution and service partner for WingScan across select European markets, was instrumental in facilitating the agreement with IKO. The European launch of WingScan reaffirms TARGAN’s commitment to advancing animal protein production globally by delivering scalable, next-generation automation that meets the increasing demands of the poultry industry.

Area Sales Manager, Tomasz Zimnicki mentioned that the collaboration provided a tremendous opportunity to meet the specific needs of the European market. "IKO is well-positioned to fully capitalise on the downstream benefits at every stage of production—from hatchery to farm to processing plant—maintaining a strong competitive edge. We are excited about the continued collaboration between TARGAN and Viscon and are fully prepared to provide the highest quality support and service as more customers adopt the WingScan system,” said Zimnicki.